genetic counseling Aug 18, 2022 Dana-Farber Educating Black, Latinx Patients Hoping to Boost Pancreatic Cancer Genetic Risk Testing Premium May 19, 2022 UC Davis Looks to Expand Genetic Breast Cancer Risk Education, Outreach for Hispanic Women Premium Mar 29, 2022 Genetic Testing Challenges in Oncology: Doc Tells Patient With Familial Risks to Get DTC Testing Feb 23, 2022 Genetic Testing Challenges in Oncology: Muddled Reporting, Interpretation of PALB2 VUS Jan 27, 2022 Genetic Testing Challenges in Oncology: Myotonic Dystrophy Signs Missed in Uterine Cancer Patient Dec 22, 2021 Genetic Testing Challenges in Oncology: Prior Retinoblastoma Not Considered in Test Ordering Nov 29, 2021 Genetic Testing Challenges in Oncology: No Follow-up on Insurer Denial Delays Cancer Risk Management Oct 28, 2021 Genetic Testing Challenges in Oncology: Same Multigene Cancer Risk Panel Not Right for All Oct 18, 2021 Physician Bias May Contribute to Lower Genetic Testing Rates Among Black Women, Study Suggests Oct 18, 2021 Outcomes4Me Incorporates NCCN Hereditary Cancer Risk Testing Guidelines Into Patient-Facing App May 28, 2021 Genetic Testing Challenges in Oncology: Immigrant Mislabeled as BRCA-Positive, Regrets Ovary Removal Apr 29, 2021 Genetic Testing Challenges in Oncology: BRCA1-Positive Patient Told Paternal Cancer Risk Unimportant Mar 26, 2021 Genetic Testing Challenges in Oncology: BRCA1-Positive Breast Cancer Patient Told She's Negative Mar 1, 2021 Genetic Testing Challenges in Oncology: Forged Genetic Test Report Leads to Incorrect Management Jan 29, 2021 Genetic Testing Challenges in Oncology: Peutz-Jeghers Misdiagnosis Causes Medical, Family Confusion Dec 29, 2020 My Gene Counsel, Genomet Develop Decision Support Solution for Precision Cancer Care Dec 22, 2020 Genetic Testing Challenges in Oncology: Woman Without High Breast Cancer Risk Recommended Surgery Nov 25, 2020 Genetic Testing Challenges in Oncology: BRCA2-Positive Healthy Young Man Recommended Mastectomy Nov 23, 2020 Tumor, Germline Testing of Cancer Patients Can Give Discordant Results Premium Nov 23, 2020 Multigene Panel Germline Testing of Cancer Patients Detects Unexpected Pathogenic Variants Premium Load More Breaking News Flare Therapeutics Raises $123M in Oversubscribed Series B Funding Round William Blair Initiates Coverage of MDxHealth With Outperform Rating White House Report Outlines Goals to Advance Genomic Research, Precision Therapy Development In Brief This Week: Fore Biotherapeutics, RayzeBio, Gilead Sciences, Atossa Therapeutics Bayer to Assess Nubeqa in High-Risk, Early-Stage Hormone-Sensitive Prostate Cancer BridgeBio Begins Phase I/II Study of SHP2 Inhibitor, Opdivo in KRAS-Mutant Solid Tumors